News & Insight
News
Five new teams selected to take on cancer’s toughest challenges
Today we’re excited to announce the five new global teams that have been selected to each receive up to $25m in Cancer Grand Challenges funding over five years to take on four of cancer’s toughest challenges. In March 2023, we announced…
Latest publication
News and insight archive
Video
Patient advocate Helen Matthews meets co-investigator Owen Sansom to discuss SPECIFICANCER’s latest findings, how working cross-discipline enables ‘big strides forward’ and the unique, important perspectives brought to…
News
New findings from the OPTIMISTICC team reveal aspirin’s antibacterial activity against Fusobacterium nucleatum, an oncomicrobe known to drive colorectal cancer.
OPTIMISTICC’s Caitlin Brennan, postdoctoral fellow and…
News
By distinguishing between people with ductal carcinoma in situ (DCIS) who will develop invasive breast cancer and those who won’t, the Cancer Grand Challenges PRECISION team could spare thousands of women around the…
Video
Look inside the IMAXT team’s virtual reality lab, ahead of its release later this year, as the team calls for volunteers to help test the software.
A core component of the Cancer Grand Challenges IMAXT programme,…
News
Findings from the OPTIMISTICC team point towards a global microbiome signature for colorectal cancer that could help improve the way we detect the disease.
Colorectal cancer is the third most common cancer in the world…
Blog
In October, we posed 9 new challenges to the research community, each with the potential to change the way we think about cancer. Through our blog series, members of our Cancer Grand Challenges Scientific Committee…
Video
We recently held a webinar with the American Association for Cancer Research (AACR) providing an overview of the Cancer Grand Challenges partnership between Cancer Research UK and the US National Cancer Institute. …
News
New findings from the Cancer Grand Challenges PRECISION team suggest adipocyte size and COX2 expression could help to identify which people with ductal carcinoma in situ (DCIS) are at high-risk of developing invasive…
Blog
Patient advocate Candace Henley and physician-scientist Kimmie Ng are members of the Cancer Grand Challenges OPTIMISTICC team. Together they have helped to set up the programme's flagship study, MICROCOSM.
An…